The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation;Gubitak perifernog vidnog polja nakon terapije proliferacijske dijabeticne retinopatije dvjema različitim tehnikama panretinalne fotokoagulacije

Acta Medica Croatica

Volumn 61, Issue 2, 2007, Pages 149-152

  Kovačić, Željko ^a   Ivanišević, Milan ^a   Karelović, Deni ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Panretinal photocoagulation; Visual peripheral field loss

Indexed keywords

ARTICLE; BLINDNESS; DIABETIC RETINOPATHY; DISEASE SEVERITY; INDUSTRIALIZATION; LASER COAGULATION; MEDICAL ASSESSMENT; OUTCOME ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VISUAL FIELD; VISUAL FIELD DEFECT; ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; VISUAL FIELDS;

EID: 34547558265     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Klein R, Klein BEK, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992; 15: 1975-91.
2. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report No 8. Invest Ophthalmol Vis Sci 1981; 88: 583-600.
3. Early treatment diabetic retinopathy study research group: Early photocoagulation for diabetic retinopathy, ETDRS report N 9. Ophthalmology 1991; 98(Suppl): 765-85.
4. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina 1985; 5: 5-10.
5. Davis MD. Proliferative diabetic retinopathy. U: Ryan SJ, ur. Retina. 2. ed. St Louis: CV Mosby Co, 1994, 1319-59.
6. Štriga M, Katušić D. Traumatic lesions and complications after laser photocoagulation treatment of diabetic retinopathy. Diab Croat 1990; 19: 87-98.
7. Štriga M, Katušić D, Ćurković T. Functional lesions and results following argon laser treatment for diabetic retinopathy. Diab Croat 1990; 19: 99-108.
8. Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full-versus mild-scatter coagulation. Int Ophthalmol 1998; 22: 313-19.
9. Vaughan DG, ASbury T, Riordan-Eva P. General Ophthalmology. Norwalk: Appelton & Lange, 1995, 410.
10. Laktić N, Čerfalvi A, Katušić J. Komparacije nakon fotokoagulacije dijabetične retinopatije. U: Čupak K, Škrabalo Z, ur. Dijabetes i oko. Zagreb: SNL, 1981, 229-39.
11. McDonald HR, Shatz H. Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1985; 92: 388-93.
12. Štriga M. Komplikacije nakon argon laserske fotokoagulacije u tretmanu dijabetičke retinopatije. U: Čupak K i sur. Postoperativne komplikacije u oftalmologiji. Beograd-Zagreb: Medicinska knjiga, 1987, 204-16.
13. Henricson M, Heila A. Effect of panretinal laser photocoagulation on vision visual acuity, visual fields and on subjective visual impairment in proliferative and early proliferative diabetes retinopathy. Acta Ophthalmol (Copehn) 1994; 72: 570-5.
14. Prskavec FH, Fulmek R, Kleman C, Stelzer N. Changes in the visual fild and dark adaption following panretinal photocoagulation in diabetic retinopathy. Klin Monatsbl Augenheilkd 1986; 189: 385-7.
15. Plumb AP, Swan AV, Chignel AH, Shilling JS. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol 1982; 66: 213-8.
16. Blankenship GW. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1988; 95: 170-7.
17. Hercules BL, Wozencroft M, Gayed II, Jaecok J. Periferal retinal ablation in the treatment of proliferative diabetic retinopathy during pregnancy. Br J Ophthalmol 1980; 64: 87-93.
18. Kimmel AS, Magargal LE, Tasman WS. Proliferative sickle retinopathy and neovascularization of the disc: regression following treatment with retinal scatter laser photocoagulation. Ophthalmic Surg 1986; 17: 20-2.
19. Aylward GW, Pearson RV, Jegger JD, Hamilton AM. Extensive argon laser photocoagulation in treatment of proliferative diabetic retinopathy. Br J Ophthalmol 1989; 73: 197-201.
20. Vine AK. The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy. Ophthalmology 1985; 92: 1532-7.
21. Wade EC, Blankenship GW. The efect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1990; 228: 226-31.
22. Zhang CF. Clinical study on preproliferative and proliferative diabetic retinopathy. Chung Kuo I Hsueh Yuan Hsueh Pao 1989; 11: 224-5.
23. Asher R, Hunt S, Hamilton AM, Towsend C. Photocoagulation for optic disc new vessels in diabetic mellitus. Int Ophthalmol 1981; 3: 78-85.
24. Atmaca LS, Idil A, Gunduz K. Dye laser treatment in proliferative diabetic retinopathy and maculopathy. Acta Ophthalmol Scand 1995; 73: 303-7.
25. Odonoghue HN. Laser treatment in diabetic retinopathy. Trans Ophthalmol Soc UK 1982; 102: 468-70.
26. Zhang CF. Laser tretament for pre-proliferative and proliferative diabetic retinopathy. Chung Hua Yen Ko Tsa Chin 1989; 24,: 329-32.
27. Khosla PK, Gupta V, Tewari HK, Kumar A. Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy. Ophthalmic Surg 1993; 24: 256-61.